Skip to main content
Equibles

BLAIR WILLIAM & CO/IL

Position in TLX — Telix Pharmaceuticals Ltd

CIK 902367 CHICAGO, IL
Back to TLX Full portfolio

Position in TLX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$1,418,017
+$1,201,072 QoQ
Shares Held
122,985
+811.0% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 62 holders
Holding Since
Jun 2025
2 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in TLX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BLAIR WILLIAM & CO/IL holds $184,064,705 across 61 Biotechnology names. TLX ranks #20 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
 513,573 $36,283,932
2 TWST
Twist Bioscience Corp
 256,556 $26,394,481
3 ARGX
Argenx SE
 27,666 $25,667,684
4 VKTX
Viking Therapeutics, Inc.
 416,766 $16,258,041
5 EXEL
Exelixis, Inc.
 243,215 $13,233,328
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 18,400 $9,139,832
7 SLDB
Solid Biosciences Inc.
 756,277 $7,555,207
8 AXSM
Axsome Therapeutics, Inc.
 23,450 $5,739,856

All Filings in TLX

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,418,017 122,985
2025-06-30 $216,945 13,500